Live Breaking News & Updates on Sage Therapeutics Company Profile

Stay updated with breaking news from Sage therapeutics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sage Therapeutics (NASDAQ:SAGE) Earns Neutral Rating from Analysts at Robert W. Baird

Robert W. Baird assumed coverage on shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a neutral rating and a $15.00 price target on the biopharmaceutical company’s stock. Several other brokerages have also recently commented on SAGE. Truist Financial reduced their target price on […] ....

New Zealand General , New Zealand , Robertw Baird , Vanguard Group Inc , Wellington Management Group , Sage Therapeutics Company Profile , Bellevue Group , Goldman Sachs Group , Sage Therapeutics Inc , Sage Therapeutics , Free Report , Get Free Report , Management Group , Palo Alto Investors , Alto Investors , Sage Therapeutics Daily ,

Sage Therapeutics (NASDAQ:SAGE) Raised to "Hold" at Baird R W

Baird R W upgraded shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) to a hold rating in a research note issued to investors on Wednesday, Zacks.com reports. A number of other analysts have also weighed in on the company. Wedbush reaffirmed a neutral rating and set a $24.00 price objective on shares of Sage Therapeutics […] ....

United States , Goldman Sachs Group , First Advisors Inc , Canaccord Genuity Group , Lazard Asset Management , Virtu Financial , Quest Partners , Sage Therapeutics Company Profile , Sage Therapeutics Inc , China Universal Asset Management Co , Morgan Stanley , Sage Therapeutics , Free Report , Genuity Group , Therapeutics Stock Down , Get Free Report , Asset Management , Universal Asset Management , First Advisors , Sage Therapeutics Daily ,

Sage Therapeutics (NASDAQ:SAGE) Trading Down 4.2%

Sage Therapeutics (NASDAQ:SAGE) Trading Down 4.2%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Zurcher Kantonalbank Zurich Cantonalbank , First Advisors Inc , Sage Therapeutics Company Profile , Sage Therapeutics Inc , Jpmorgan Chase Co , China Universal Asset Management Co , Needham Company , Quest Partners , Sage Therapeutics , Get Free Report , Universal Asset Management , Kantonalbank Zurich Cantonalbank , First Advisors , Handelsbanken Fonder , Sage Therapeutics Daily ,

Sage Therapeutics (NASDAQ:SAGE) Given New $28.00 Price Target at JPMorgan Chase & Co.

Sage Therapeutics (NASDAQ:SAGE) Given New $28.00 Price Target at JPMorgan Chase & Co.
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New Zealand General , New Zealand , Primecap Management Co , Algert Global , Wellington Management Group , Vanguard Group Inc , Jpmorgan Chase Co , Sage Therapeutics Inc , Rafferty Asset Management , Needham Company , Goldman Sachs Group , Royal Bank , Morgan Stanley , Sage Therapeutics Company Profile , Sage Therapeutics , Free Report , Get Free Report , Management Group , Asset Management , Primecap Management , Sage Therapeutics Daily ,

Royal Bank of Canada Cuts Sage Therapeutics (NASDAQ:SAGE) Price Target to $15.00

Sage Therapeutics (NASDAQ:SAGE – Free Report) had its target price cut by Royal Bank of Canada from $26.00 to $15.00 in a report released on Friday morning, Benzinga reports. They currently have a sector perform rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. Oppenheimer reduced their […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments Co , Canaccord Genuity Group , Sage Therapeutics Inc , Harbor Capital Advisors Inc , Morgan Stanley , Sage Therapeutics Company Profile , Royal Bank , Sg Americas Securities , Sage Therapeutics , Free Report , Genuity Group , Get Free Report , Capital Advisors , Kantonalbank Zurich Cantonalbank , Mirae Asset Global Investments , Asset Global Investments , Sage Therapeutics Daily ,